Thanks to the prospect of a mutated H1N1, Americans will enter this year’s flu season with trepidation. Researchers are closer to developing vaccines, but the only way to verify that the immunizations are safe is to test them on human volunteers. We talk to one such brave subject, Gordon Potts, who got a vaccine yesterday. We also talk to Dr. Mark Mulligan, executive director of the Hope Clinic at the Emory Vaccine Center.
There is no paywall on the story you just read because a community of dedicated listeners and readers have contributed to keep the global news you rely on free and accessible for all. Will you join the 319 donors who have supported The World so far? From now until Dec. 31, your gift will help us unlock a $67,000 match. Donate today to double your impact!